Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-08

Clinical Trial Update: Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the combination of raltegravir and darunavir in antiretroviral-naive HIV patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Darunavir (darunavir)
  • Raltegravir (raltegravir)

Snippet

Sponsor: Dallas VA Medical Center | Conditions: HIV Infections | Phase 4 | Status: COMPLETED